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Clobazam is the first and only 1,Sbenzodiazepine to be used in the management of epilepsy. The use and effectiveness of 
oral clobazam in patients with status epilepticus has only been previously described in one study of 16 case’s, even of whom 
were in complex partial status. We have used clobazam in four patients with EEG-proven partial status epilepticus refractory 
to standard antiepileptic drugs. In all cases, except one, the seizure activity was controlled within 2 hr of administering 
clobazam. Our four patients responded promptly to an oral loading of clobazam which was approximately twice the usual 
daily maintenance dose. The drug was well tolerated and no adverse effects were seen. Clobazam’s effectiveness as a first-line 
agent remains to be studied. Further controlled studies are recommended. 
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INTRODUCTION 
Clobazam is the first and only 1,Sbenzodiazepine 
to be used in the management of epilepsy’. It dif- 
fers from other antiepileptic benzodiazepines in that 
its nitrogen radicals are located in positions 1 and 5 
rather than 1 and 4’. Like all other benzodiazepines, 
clobazam acts through the benzodiazepine receptors 
on the gamma-aminobutyric acid (GABA) receptor 
complex. 
Clobazam is rapidly and almost completely ab- 
sorbed (87%) with peak plasma levels achieved 
within 1 to 4 hs. The drug is relatively insoluble and 
is therefore not available for intravenous or intramus- 
cular use’. This drug is, extensively metabolized to N- 
desmethylclobazam which contributes significantly to 
clobazam’s antiepileptic activity4. 
In experimental models as well as in humans, 
clobazam has been shown to be an effective broad 
spectrum antiepileptic agent against partial and gen- 
eralized seizures which is more effective after oral 
administration than other benzodiazepines’ .
The use and effectiveness of oral clobazam in pa- 
tient with status epilepticus has only been previ- 
ously described in one study of 16 cases, seven of 
whom were in complex partial status’. We have used 
clobazam in 4 patients with EEG-proven partial sta- 
tus epilepticus refractory to standard medication. In 
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all cases, except one, the seizure activity was con- 
trolled within 2 hr of administering clobazam. 
CASE 1 
A 46-year-old right-handed man presented with a 4- 
week history of episodic ‘confusion’. These episodes 
had a sudden onset, lasted less than 1 min and oc- 
curred several times per hour. During these events he 
would stop talking and would have no recollection 
of this. The day before admission he had suffered a 
brief episode of loss of consciousness. Since then, he 
had been awake but withdrawn. No abnormal move- 
ments were observed. His past medical history was 
positive for alcohol abuse, seizure disorder (asymp- 
tomatic for 4 years and off medication for 2 years) and 
he was HIV positive for the past 6 years. The physi- 
cal examination disclosed a thin man in no acute dis- 
tress, afebrile with normal vital signs. The neurologi- 
cal exam showed an alert patient disoriented to place 
and person, with no speech difficulty. His memory 
was severely impaired. He could not do serial sevens 
and was not able to repeat 3 words after 3 min. Dur- 
ing the examination he had several episodes where 
his eyes would open and stare, he would not be able 
to continue the conversation and would only say he 
was having ‘a spell’. In between he was withdrawn, 
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but would answer questions and follow commands. 
At times he looked towards the right. No abnormal 
movements were noted. Blood biochemistry, ECG 
and chest x-ray were normal. CT scan of the head 
showed mild cortical atrophy. The CSF examination 
was normal including gram stain, cultures and India 
Ink preparation. EEG showed build-up of right fron- 
totemporal rhythmic theta activity during the seizures 
which recurred every few min (Fig. la and b). During 
that time the patient was unresponsive and showed 
some automatisms. 
The patient was treated with phenytoin 18 mg/kg IV 
and lorazepam 4 mg IV. Despite treatment the seizure 
activity continued for 12 hr but responded completely 
within 1 hr of a single oral dose of clobazam 70 mg. 
EEG 3 hr after the dose revealed no seizure activity. 
Serum phenytoin level measured 2-hr after the bo- 
lus was 68 pmol/L and serum clobazam level was 
4.1 pmol/L. 
CASE 2 
A 30-year-old left-handed woman started to experi- 
ence persistent uncontrolled contractions in her right 
biceps on the night prior to admission. There was no 
spread of the movement into neck, face or right leg. 
She did not experience loss of consciousness, bowel 
or bladder incontinence. She had a long pasthistory of 
epilepsy, with generalized seizures from the age of 6 
years. Since then she had continued to experience pe- 
riodic focal motor seizures of the right arm. Medica- 
tion on admission were carbamazepine 1000 mg/day, 
phenytoin 150 mg/day and clonazepam 6 mg/day. 
Physical examination showed an alert and very anx- 
ious woman distressed over her uncontrollable arm 
movements. She was afebrile, BP 100/70, HR 70 and 
RR 16. Neurological examination showed her to be 
oriented in all spheres and cooperative. Examination 
of the extremities disclosed that her right hand was 
smaller than her left and there were repetitive clonic 
contractions of the right biceps. Movement, power 
and tone were normal. Deep tendon reflexes were in- 
creased in the right arm. Blood biochemistry, ECG 
and chest x-ray were normal. Drug levels on admis- 
sion were: phenytoin 41 pmol/L and carbamazepine 
26 pmol/L. EEG showed frequent left fronto-central 
spikes which were accompanied by twitching move- 
ments of the right biceps muscle (Fig. 2). 
The patient received additional phenytoin IV and 
several doses of lorazepam 1 mg IV. Despite the 
treatment the seizure activity persisted for 10 hr. 
She was then loaded with 60 mg of clobazam orally 
and her seizure activity resolved completely in 2 hr. 
Serum clobazam measured 2 hr after the dose was 
2.1 pmol/L. 
CASE 3 
A 7 l-year-old right-handed woman was admitted, af- 
ter having an episode of seizures and being acutely 
confused. She had a past medical history of chronic 
obstructive pulmonary disease, a right frontal in- 
farct and was doing well until a few days prior to 
admission when she developed an upper respiratory 
tract infection with fever and diarrhoea. On the morn- 
ing of admission, she was found unresponsive in bed 
by her husband with frothy and blood-tinged saliva 
and sputum, and incontinence of urine. Physical ex- 
amination showed an alert and agitated woman. She 
was afebrile, BP 170/90, HR 120 and RR 20. Neck 
was supple. There were anterior tongue lacerations 
and multiple ecchymoses of the right forearm. Neu- 
rological examination showed her to oriented to place 
and time, and she recognized family. She was coher- 
ent but inappropriate at times and restless. CT scan of 
the head revealed a hypodensity in the right frontal 
lobe, felt to represent an old infarct. The CSF ex- 
amination was normal. The patient was treated with 
phenytoin 16 mg/kg IV, diazepam 9 mg IV and mi- 
dazolam 2 mg IV. For the next 24 hr, the patient 
remained confused with episodes of agitation and a 
left-sided hemiparesis with a Babinski sign. An EEG 
revealed a continuous discharge of focal spike waves 
recorded from the right frontal region (Fig. 3). At 
times, the right-sided discharges came close to re- 
sembling periodic lateralized epileptiform discharges 
(PLEDs). An MRI of the head revealed multiple bilat- 
eral hyperintense lesions in subcortical and periven- 
tricular regions-most likely ischemic in nature. The 
patient was started on clobazam with a loading dose 
of 60 mg and a maintenance dose of 20 mg per day, 
since even with a therapeutic level of 53 kmol/L for 
phenytoin, she remained agitated and confused. In 
the next 2 days, the confusion cleared and the pa- 
tient started to be more oriented without episodes of 
agitation. The left-sided hemiparesis improved and a 
repeat EEG revealed no evidence of epileptic activity. 
CASE 4 
A 49-year-old female presented with a 6-day history 
of malaise, diplopia, blurred vision and dizziness. 
Upon admission, she experienced three episodes of 
generalized tonic-clonic seizures followed by contin- 
uous simple partial motor seizures in the right hand 
and arm. Her past medical history include psoriatic 
arthritis and non-insulin dependent diabetes mellitus. 
Examination showed a drowsy woman with recur- 
rent clonic movements of right hand and arm. She 
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Fig. 1: EEG in Case 1 showing seizure beginning in left frontotemporal area (Fpl-F3 and F7-T3) and lasting approximately 1 min. 
During this time the patient was motionless and unresponsive. 
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Fig. 2: EEG in Case 2 done during status showing very frequent lefi central (C3) spikes which were accompanied by right arm 
twitching. 
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Fig. 3: EEG in Case 3 done during status showing spikes and sharp waves resembling PLEDs recorded from the right 
fronto-temporal area. 
Fig. 4: EEG is Case 4 during status showing left mid-temporal PLEDs extending into central regions. 
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was febrile and BP100/60. She followed simple com- 
mands and answered questions with yes/no. She had 
a mild right hemiparesis and Babinski sign. CT scan 
of the head (with and without contrast) and CSF ex- 
amination were normal. She was initially given only 
200 mg phenytoin IV due to hypotension. The patient 
was subsequently treated with phenytoin 1150 mg IV 
and lorazepam 3 mg IV. Partial seizures persisted 
and EEG revealed nearly continuous left rnidtempo- 
ral spike-wave and sharp wave discharges as well 
as diffuse slowing. The discharges resembled PLEDs 
at times (Fig. 4). Phenytoin level was 75 pmol/L. 
Clobazam 70 mg was given orally 16 hr following 
admission and seizures stopped within 30 min. She 
became more alert and oriented. An MRI of the head 
(with and without gadolinium) showed subtle areas 
of increased intensity on T2-weighted scans affecting 
left frontal, parietal and temporal areas and possibly 
the right mesial temporal areas. In addition there were 
small petechial haemorrhages in the cerebral cortex 
bilaterally. The diagnosis was felt to be vasculitis, 
possibly due to lupus but viral encephalitis, possibly 
due to herpes simplex could not be ruled out. She was 
treated with corticosteroids, acyclovir and a combina- 
tion of clobazam (10 mg qam and 20 mg qhs for 4 
days then 10 mg twice daily for 3 days then 10 mg 
per day for 5 days) for 12 days and carbamazepine. 
Seizures did not recur and a repeat EEG showed only 
diffuse slowing. 
tonic and seven in complex partial status. These au- 
thors found that 15 of the patients responded within 
25 min of administering clobazam of 6 of these had 
complex partial status5. 
Our four patients with proven partial status re- 
sponded promptly to an oral loading of clobazam 
which was approximately twice the usual daily main- 
tenance dose. An important feature of these cases was 
that they had already failed to respond to conventional 
loading doses of phenytoin and lorazepam. The drug 
was well tolerated and no adverse effects were seen. 
Patients did not become over-sedated or stuporous 
following the loading dose. 
In conclusion, clobazam given orally in a loading 
dose in partial status epilepticus is practical and po- 
tentially effective. Our experience suggests its effi- 
cacy when used following conventional intravenous 
use of antiepileptic drugs in status. Whether it would 
be effective as a first-line agent remains to be stud- 
ied. The pharrnacokinetics, including rapid absorption 
and relatively long half-life, and safety profile of the 
drug favours its use in these scenarios and further 
controlled studies are recommended. 
REFERENCES 
I. 
2. 
DISCUSSION 
Shorvon. S. D. Benzodiazepines. Clobazam. In: Anriepilepric 
Drugs, &/I Ed (Eds R. H. Levy, R. H. Mattson and B. S. Mel- 
drum) New York, Raven Press, 1995: pp. 763-777. 
Gastaut, H. and Low, M. D: Antiepileptic properties of 
clobazam. a l$benzodiazepine in man. Epiiepsia 1979; 20: 
437-446. 
3. 
Simple partial status epilepticus, especially when it 
is due to an acute brain lesion, may be resistant to 
conventional antiepileptic drugs. Complex partial sta- 
tus, although less frequently encountered, may be pro- 
longed and refractory &’ Some of these patients, who . 
have consciousness preserved or lucid intervals be- 
tween their seizures, are capable of taking oral medi- 
cation which offers the possibility of early out-patient 
management. This assumes importance in patients 
who are subject to recurrent bouts of partial status. 
4. 
5. 
6. 
Clobazam has been shown in several European 
and Canadian studies to be an effective, broad- 
spectrum antiepileptic add-on agent despite the devel- 
opment of tolerance in approximately half of excel- 
lent responders ‘**-“. There is one report of clobazam 
administered as a loading dose (0.5 to 1.7 mg/kg, 
mean 1.08 mg/kg) in 16 patients in status epilepticus. 
Six were in absence status, one in myoclonic, one in 
7. 
8. 
Rupp, W., Badian, M.. Christ, 0. et al. Pharmacokinetics of 
single and multiple doses of clobazam in humans. Br. J. C/in. 
Pharmac. 1979; I: 5 IS-57s. 
Kuch, A. Clobazam: chemical aspects of the 1,4 and I.5 
benzodiazepines. Br. J. C/in. Phamoc. 1979; 7: l7S-21s. 
Tinuper, P., Aguglia. U. and Gastaut, H., Use of clobazam 
in certain forms of status epilepticus and in startle-induced 
epileptic seizures. Epilepsio 1986; 27 (Suppl. 1): Sl8S26. 
Tremain, D. M. and Delgado-Escueta, A. V. Complex partial 
status epilepticus. In: Advances in Neurology, Vol. 34: Smus 
Epilepticus (Eds A. V. Delgado-Bscueta, C. G. Wasterlain, 
D. M. Treiman and R. I. Porter). New York, Raven Press, 
1983: pp. 69-81. 
Cascino, G. D. Nonconvulsive status epilepticus in adults and 
children. Epilepsiu 1993; 34 (Suppl. 1): S2lS28. 
Guberman, A.. Couture, M., Blashcuk, K. and Sherwin, A. 
Add-on trial of clobazam in intractable adult epilepsy with 
plasma level correlations. Can. J. Nerrml. Sci. 1990; 17: 3 I l- 
316. 
9. 
10. 
Canadian Clobazam Cooperative Group. Clobazam in the 
treatment of refractory epilepsy: the Canadian experience. 
Epilepsia 1991; 32: 407-416. 
Singh, A., Guberman, A. and Boisvert, D. Clobazam in long- 
term epilepsy treatment: sustained responders versus those 
developing tolerance. Epilepsiu 1995; 36: 798-803. 
